What is Eszopiclone?
Eszopiclone is a prescription drug primarily used to treat insomnia, which affects millions of people worldwide. For instance, according to the National library of health, numerous studies from across the globe have found that 10%–30% of the population suffers from insomnia, with some even recording rates of 50%–60%. It belongs to the group of medicines called as non-benzodiazepine hypnotics, and it works by altering brain chemicals that may be out of balance in those who have sleep issues.
The Growing Elderly Population is Driving the Demand for the Eszopiclone Market
The Eszopiclone Market is mostly driven by the aging population because of this group's higher prevalence of sleep issues. An increased frequency of sleep-related disorders, particularly insomnia, among older persons is naturally correlated with changing demographic patterns and the aging of a sizable segment of the worldwide population. For instance, around 50% to 70% of the people who are above the age of 65 years have symptoms of insomnia. Insomnia is more common among elderly people than among younger people. As the number of elderly population increase, there would be increase in sleep related issue in the particular demographics which may result in the increase in demand for Eszopiclone medicine.
After a series of orderly declines, the old population growth rate in India experienced an enormous increase starting in 2001. The growth rate was predicted to be five times that of the whole population between 2021 and 2031. As people become older, insomnia, which is characterized by problems falling asleep, staying asleep, or getting restorative sleep, becomes more common and chronic. Medical diseases include chronic pain, arthritis, cardiovascular disease, and respiratory illnesses, all of which can interfere with sleep, regularly cause sleep disruptions in elderly people. Additionally, aging-related metabolic changes and consumption of drugs may result in side effects that increase sleep issues. For instance, according to the National institute of health, Eszopiclone prescription for elders who have trouble sleeping should start at 2 mg at night.
Elderly sleep issues must also be addressed since untreated insomnia can have a variety of negative health effects. Cognitive decline, mood disorders including sadness and anxiety, an enhanced risk of falls and fractures, and even a higher mortality risk may be among them. Eszopiclone is therefore essential in addressing the specific sleep issues that the older population faces.
Conclusion
The market for Eszopiclone, a medication commonly used to treat insomnia, is significantly influenced by the aging population due to the higher prevalence of sleep-related issues among older individuals. Healthcare providers and policymakers should prioritize the availability and accessibility of Eszopiclone to meet the growing needs of the aging population.
Author's Detail:
Nisha Deore /
LinkedIn
Nisha Deore is a highly skilled Research Analyst with over three years of experience specializing in the agriculture and food & beverage sectors. Her expertise encompasses secondary research, data mining, competitive analysis, and the development of detailed collateral and PR materials. Known for her meticulous approach, Nisha designs robust research methodologies and delivers actionable insights that support her organization’s commercial and financial objectives.
In her current role, Nisha manages research for both the agriculture and food & beverage categories, leading initiatives to uncover market opportunities and enhance competitive positioning. Her strong analytical skills and ability to provide clear, impactful findings have been crucial to her team’s success. With a deep passion for both sectors and a commitment to continuous professional development, Nisha remains an invaluable asset in the dynamic landscape of market research.
